‘Sotrovimab’: New drug trumps former vaccines and beats COVID-19, study reveals

According to the local health authorities in Abu Dhabi, Sotrovimab led to a recovery rate of 97% patients.

Reportedly, more than half of all the recipients were 50 above and almost all had accompanying medical issues, such as cancer, heart disease or diabetes.

Health experts underlined that ‘Sotrovimab’ is safe and effective, especially when coronavirus infection is detected early.

Dr Khawthar Al Ameri, manager, Covid-19 Prime Assessment Center, Al Mafraq stated that “Sotrovimab is an anti-viral medicine, which reduces the death rate by 85%”.

“It doesn’t need any modification for different age groups among adults nor for pregnant women, children above the age of 12 years, vulnerable groups or people with chronic diseases. It is administered through an intravenous drip in 30 to 40 minutes,” he added.

The UAE is the first country in the world to receive the jab following an agreement between the DoH, Rafed, GlaxoSmithKline and Etihad Cargo.

The medication was received in Abu Dhabi in mid-June.

Meanwhile, more than 3.5 billion doses of Covid-19 vaccines have been administered around the globe.

However, many countries have persistently high rates of infection despite leading inoculation campaigns. For example, in United Kingdom, almost 55,000 people tested positive on Saturday.

Medics can now have confidence in the new drug that prevents the tragedy of death from Covid-19.

However, with each month that passes, new drugs, vaccines, behavioural measures and treatment methods will be found by medical researchers who are learning more about the deadly virus.